Gene expression profile towards the prediction of patient survival of gastric cancer

Biomedicine and Pharmacotherapy

Volumn 64, Issue 2, 2010, Pages 133-139

  Xu, Zhen Yu ^a   Chen, Jia Shun ^a   Shu, Yong Qian ^a  

^a NONE   (China)

Author keywords

Gastric cancer; Gene expression profile; Prognostic biomarker

Indexed keywords

ANGIOPOIETIN 2; BETA1 INTEGRIN; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR B; PROTEIN NME4; PROTEIN PLAU; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MATHEMATICAL MODEL; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH SURGERY;

ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77349090672     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.06.021     Document Type: Article

References (59)

1. Dicken B.J., Bigam D.L., Cass C., et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005, 241(1):27-39. [PMID:15621988].
2. Hohenberger P., Gretschel S. Gastric cancer. Lancet 2003, 362(9380):305-315. [PMID:12892963].
3. Chen C.N., Lin J.J., Chen J.J., et al. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 2005, 23(29):7286-7295. [PMID:16145069].
4. Marchet A., Mocellin S., Belluco C., et al. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol 2007, 14(3):1058-1064. [PMID:17106627].
5. Yakata Y., Nakayama T., Yoshizaki A., et al. Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol 2007, 30(2):437-442. [PMID:17203226].
6. Wei D., Gong W., Kanai M., et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005, 65(7):2746-2754. [PMID:15805274].
7. Mrena J., Wiksten J.P., Thiel A., et al. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res 2005, 11(20):7362-7368. [PMID:16243808].
8. Dhar D.K., Wang T.C., Tabara H., et al. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res 2005, 11(18):6472-6478. [PMID:16166422].
9. Ji Z., Yang G., Shahzidi S., et al. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett 2006, 244(2):182-189. [PMID:16427735].
10. Gong W., Jiang Y., Wang L., et al. Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer. Clin Cancer Res 2005, 11(16):5778-5783. [PMID:16115916].
11. Nagahara H., Mimori K., Utsunomiya T., et al. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res 2005, 11(19 Pt 1):6800-6806. [PMID:16203767].
12. Mashino K., Sadanaga N., Yamaguchi H., et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002, 62(10):2937-2941. [PMID:12019175].
13. Jazaeri A.A., Awtrey C.S., Chandramouli G.V., et al. Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clin Cancer Res 2005, 11(17):6300-6310. [PMID:16144934].
14. Lau S.K., Boutros P.C., Pintilie M., et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 2007, 25(35):5562-5569. [PMID:18065728].
15. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006, 66(10):5330-5337. [PMID:16707459].
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159. [PMID:2440339].
17. Rajeevan M.S., Vernon S.D., Taysavang N., et al. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 2001, 3(1):26-31. [PMID:11227069].
18. Tjandra S.S., Hsu C., Goh Y.I., et al. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors. Cancer Res 2007, 67(15):7124-7131. [PMID:17671179].
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. [PMID:11846609].
20. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70. [PMID:10647931].
21. Tsatsanis C., Spandidos D.A. The role of oncogenic kinases in human cancer (Review). Int J Mol Med 2000, 5(6):583-590. [PMID:10812005].
22. Meyer T., Hart I.R. Mechanisms of tumour metastasis. Eur J Cancer 1998, 34(2):214-221. [PMID:9741324].
23. Detmar M. Tumor angiogenesis. J Investig Dermatol Symp Proc 2000, 5(1):20-23. [PMID:11147670].
24. Klingelhutz A.J. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 1999, 19(6A):4823-4830. [PMID:10697595].
25. Kaufmann S.H., Gores G.J. Apoptosis in cancer: cause and cure. Bioessays 2000, 22(11):1007-1017. [PMID:11056477].
26. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis 2000, 21(3):485-495. [PMID:10688869].
27. Funk J.O. Cancer cell cycle control. Anticancer Res 1999, 19(6A):4772-4780. [PMID:10697591].
28. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000, 33(5):261-274. [PMID:11063129].
29. Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci 1998, 54(6):541-548. [PMID:9676573].
30. Hynes R.O. A reevaluation of integrins as regulators of angiogenesis. Nat Med 2002, 8(9):918-921. PMID:12205444.
31. Carlson T.R., Hu H., Braren R., et al. Cell-autonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice. Development 2008, 135(12):2193-2202. [PMID:18480158].
32. Raghavan S., Bauer C., Mundschau G., et al. Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol 2000, 150(5):1149-1160. [PMID:10974002].
33. Li N., Zhang Y., Naylor M.J., et al. Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J 2005, 24(11):1942-1953. [PMID:15889143].
34. Blaess S., Graus-Porta D., Belvindrah R., et al. Beta1-integrins are critical for cerebellar granule cell precursor proliferation. J Neurosci 2004, 24(13):3402-3412. [PMID:15056720].
35. Palmantier R., George M.D., Akiyama S.K., et al. Cis-polyunsaturated fatty acids stimulate beta1 integrin-mediated adhesion of human breast carcinoma cells to type IV collagen by activating protein kinases C-epsilon and -mu. Cancer Res 2001, 61(6):2445-2452. [PMID:11289113].
36. Ramakrishnan V., Bhaskar V., Law D.A., et al. Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. J Exp Ther Oncol 2006, 5(4):273-286. [PMID:17024968].
37. Tozer S., Bonnin M.A., Relaix F., et al. Involvement of vessels and PDGFB in muscle splitting during chick limb development. Development 2007, 134(14):2579-2591. [PMID:17553906].
38. Doolittle R.F., Hunkapiller M.W., Hood L.E., et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 1983, 221(4607):275-277. [PMID:6304883].
39. Hijjawi J., Mogford J.E., Chandler L.A., et al. Platelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps. Arch Surg 2004, 139(2):142-147. [PMID:14769570].
40. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008, 22(10):1276-1312. [PMID:18483217].
41. Leitzel K., Bryce W., Tomita J., et al. Elevated plasma platelet-derived growth factor B-chain levels in cancer patients. Cancer Res 1991, 51(16):4149-4154. [PMID:1868437].
42. Wang Y., Ji M., Wang W., et al. Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer. Endocr Relat Cancer 2008, 15(1):183-190. [PMID:18310286].
43. Takahashi Y., Bucana C.D., Akagi Y., et al. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 1998, 4(2):429-434. [PMID:9516932].
44. Yang J., Mani S.A., Donaher J.L., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117(7):927-939. [PMID:15210113].
45. Watson M.A., Ylagan L.R., Trinkaus K.M., et al. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res 2007, 13(17):5001-5009. [PMID:17785550].
46. Mironchik Y., Winnard P.T., Vesuna F., et al. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005, 65(23):10801-10809. [PMID:16322226].
47. Kwok W.K., Ling M.T., Lee T.W., et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005, 65(12):5153-5162. [PMID:15958559].
48. Zhang Z., Xie D., Li X., et al. Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol 2007, 38(4):598-606. [PMID:17258791].
49. Ohuchida K., Mizumoto K., Ohhashi S., et al. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 2007, 120(8):1634-1640. [PMID:17236203].
50. Valdes-Mora F., Gomez del Pulgar T., Bandres E., et al. TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Ann Surg Oncol 2009, 16(1):78-87. [PMID:19002529].
51. Yan-Qi Z., Xue-Yan G., Shuang H., et al. Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology 2007, 39(5):470-475. [PMID:17886095].
52. McLaughlin J.N., Mazzoni M.R., Cleator J.H., et al. Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells. J Biol Chem 2005, 280(23):22172-22180. [PMID:15817447].
53. Yang S., Tang X.F., Guo L.J., et al. Correlation between the expression of thrombospondin-1 and the angiogenesis in mucoepidermoid carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 2008, 39(5):763-765. [PMID:19024308].
54. Qian X., Tuszynski G.P. Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 1996, 212(3):199-207. [PMID:8677265].
55. Dameron K.M., Volpert O.V., Tainsky M.A., et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994, 265(5178):1582-1584. [PMID:7521539].
56. Zabrenetzky V., Harris C.C., Steeg P.S., et al. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 1994, 59(2):191-195. [PMID:7927918].
57. Roberts D.D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 1996, 10(10):1183-1191. [PMID:8751720].
58. Park W.S., Park J.Y., Oh R.R., et al. A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer. Cancer Res 2000, 60(1):70-73. [PMID:10646855].
59. Kang G.H., Lee S., Kim W.H., et al. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002, 160(3):787-794. [PMID:11891177].